SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001679
Filing Date
2022-05-16
Accepted
2022-05-16 16:31:07
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syn-20220331x10q.htm   iXBRL 10-Q 1468375
2 EX-31.1 syn-20220331xex31d1.htm EX-31.1 16006
3 EX-32.1 syn-20220331xex32d1.htm EX-32.1 7254
4 GRAPHIC syn-20220331x10q001.jpg GRAPHIC 48432
  Complete submission text file 0001410578-22-001679.txt   7096539

Data Files

Seq Description Document Type Size
5 EX-101.SCH syn-20220331.xsd EX-101.SCH 53449
6 EX-101.CAL syn-20220331_cal.xml EX-101.CAL 49141
7 EX-101.DEF syn-20220331_def.xml EX-101.DEF 250463
8 EX-101.LAB syn-20220331_lab.xml EX-101.LAB 405834
9 EX-101.PRE syn-20220331_pre.xml EX-101.PRE 376754
65 EXTRACTED XBRL INSTANCE DOCUMENT syn-20220331x10q_htm.xml XML 1195564
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 22929773
SIC: 2834 Pharmaceutical Preparations